Inventor
Barbara SENNINO
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides18%
C12NMicroorganisms or enzymes12%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
A01KAnimal husbandry6%
C40BCombinatorial chemistry6%
PatentTitleYear
12,589,132CD80 extracellular domain Fc fusion proteins for treating PD-L1 negative tumors202612,365,719CD80 extracellular domain polypeptides and their use in cancer treatment202512,276,656Compositions and methods for identification of antigen specific T cells202512,247,061Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy202511,789,010Methods of treatment with CD80 extracellular domain polypeptides202311,513,113Compositions and methods for identification of antigen specific T cells202211,304,978Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to PACT PHARMA INC (2)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to FIVE PRIME THERAPEUTICS INC (3)· patent assignee history
2025Patents assigned to ADOC SSF LLC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FIVE PRIME THERAPEUTICS INC | 3 | 2023–2026 |
| ADOC SSF LLC | 2 | 2025 |
| PACT PHARMA INC | 2 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2026 |